Media Center

Molecular Diagnostics 2026–27: Market Trends & Equipment Upgrades to Watch

The molecular diagnostics market continues to evolve as laboratories respond to growing testing demand, shorter turnaround targets, broader test menus, staffing constraints, and higher expectations for quality and traceability. This article reviews key molecular diagnostics trends for 2026–27, including integrated workflows, scalable automation, multiplex PCR, digital PCR, NGS, digital integration, and near-patient testing. It also examines equipment, reagent, and workflow upgrade considerations to help laboratories plan future molecular diagnostics capacity and highlights how BioPerfectus solutions can support different testing volumes and operational requirements.

September 1, 2026 Learn More

Manual vs Automated Nucleic Acid Extraction: Pros, Cons, and Laboratory Applications

Nucleic acid extraction is a critical step in PCR, sequencing, and molecular diagnostic workflows, and the choice between manual, semi-automated, and fully automated methods can affect laboratory cost, hands-on time, throughput, and consistency. This article compares the advantages, limitations, and laboratory applications of different nucleic acid extraction approaches and explains how automation can help reduce operator-dependent variability. It also introduces the BioPerfectus Nucleic Acid Extraction System SSNP-2000B as a semi-automated solution for magnetic bead-based nucleic acid purification.

August 27, 2026 Learn More

Real-Time PCR Systems in Modern Molecular Laboratories: Throughput, Multiplexing and Workflow Integration

Real-time PCR system performance depends on more than sample capacity alone. Laboratories should consider throughput, run time, multiplexing capability, fluorescent channel separation, dual-block design, and workflow integration when selecting a system. This article explores how these factors affect laboratory efficiency and highlights how the BioPerfectus STC-96A PLUS Real-Time PCR System supports high-throughput and multiplex molecular testing through dual 48/48 reaction blocks, multiple fluorescence channels, and integration with broader PCR workflows.

August 27, 2026 Learn More

Molecular IVD Workflow Optimization: From Sample Preparation to PCR Results

Optimizing a molecular IVD workflow requires more than improving PCR amplification alone. Manual pipetting, sample handoffs, extraction variability, and repeat testing can all affect laboratory turnaround time and result consistency. This article explores how standardized nucleic acid extraction, appropriate PCR kit selection, internal controls, and precise real-time PCR systems can support a more efficient workflow. It also highlights how integrated solutions such as the BioPerfectus SAW-48 and STC-96A PLUS can connect sample preparation, amplification, and result interpretation across the testing process.

August 27, 2026 Learn More

How to Evaluate Global IVD Service: Integrated PCR Workflow and Local Support

Evaluating a global IVD supplier requires looking beyond instrument specifications to assess how the complete PCR workflow and local service infrastructure work together. This article outlines key considerations for evaluating workflow integration, automation, multiplex capabilities, data connectivity, scalability, maintenance, regulatory readiness, training, and regional technical support. It also highlights how BioPerfectus combines integrated PCR workflow solutions with global and localized service resources to support laboratory operations.

August 27, 2026 Learn More

How to Choose an Open-Platform PCR Kit Supplier

Choosing the right open-platform PCR kit supplier requires more than evaluating reagent performance alone. Laboratories should consider cross-platform compatibility, product menu diversity, system flexibility, and after-sales technical support to ensure efficient implementation and long-term operational flexibility. This article outlines the key criteria for evaluating an open-platform PCR partner and highlights how BioPerfectus combines flexible PCR reagents, STC real-time PCR systems, a broad assay portfolio, and technical support to meet diverse laboratory needs.

August 26, 2026 Learn More

Through the Lens of ADLM 2026: Three Paradigm Shifts Shaping the Global In Vitro Diagnostics (IVD) Industry

ADLM 2026 offers a window into three major shifts shaping the global IVD industry: increasingly intelligent and integrated core laboratories, more precise biological characterization through advanced diagnostic approaches, and the expansion of validated testing workflows closer to patients and communities. This article examines the technologies, workflow changes, and care-setting evolution behind these trends.

August 14, 2026 Learn More

Comparative Analysis of Maternal Group B Streptococcus Molecular PCR Screening versus Traditional Culture: Diagnostic Performance, False-Negative Dynamics, and Health Economics

Maternal Group B Streptococcus (GBS) screening plays a critical role in preventing early-onset neonatal disease. This article compares traditional culture with real-time PCR and other molecular screening strategies in terms of diagnostic performance, false-negative rates, turnaround time, temporal changes in maternal colonization, and health economic outcomes. It also examines the distinct roles of enriched prenatal NAAT and rapid intrapartum molecular testing across maternal care workflows.

August 11, 2026 Learn More

Vulvovaginal Candidiasis: New Insights into Diagnosis, Recurrence, and the Vaginal Microbiome

Vulvovaginal candidiasis (VVC) and recurrent VVC remain common yet complex conditions shaped by interactions among Candida virulence, host immunity, hormonal factors, epithelial health, and the vaginal microbiome. Because symptoms are nonspecific and asymptomatic colonization is common, laboratory detection—particularly highly sensitive molecular testing—must be interpreted alongside clinical findings. This article reviews current evidence on disease mechanisms, recurrence, microbiome composition, diagnostic challenges, antifungal management, and emerging therapeutic strategies.

August 6, 2026 Learn More

Functional Cure in Chronic Hepatitis B: Phase 3 B-Well Data Highlight the Role of HBV DNA and HBsAg Monitoring

A recently published Phase 3 study in The New England Journal of Medicine reported results from the B-Well 1 and B-Well 2 trials evaluating bepirovirsen, an investigational antisense oligonucleotide, in adults with chronic hepatitis B virus infection. The trials showed that functional cure at week 72 was achieved in a higher proportion of patients receiving bepirovirsen than placebo, with stronger responses observed among patients with lower baseline HBsAg levels. The study also highlights the importance of HBV DNA and HBsAg monitoring in finite-therapy evaluation, NA discontinuation assessment, treatment-response evaluation, and post-treatment follow-up.

July 10, 2026 Learn More